Lafayette father first in Colorado to receive newly approved pancreatic cancer drug
Key Points:
- DENVER — A Lafayette father with stage 4 pancreatic cancer is believed to be the first patient in Colorado to receive a newly approved targeted therapy.
- Colin Kiesel recently started taking Zenocutuza